Moreover, a phase 1 study has shown that retatrutide may decrease appetite and increase sensation of fullness and satiety in patients with type 2 diabetes [2]
Abrahamsson, M
You might be wondering why I dont tell you to go out and grab yourself some Ozempic if GLP-1 agonists are so great at helping folks lose weight
Bjrnholm KD, Skovsted GF, Mitgaard-Thomsen A, Rakipovski G, Tveden-Nyborg P, Lykkesfeldt J, Povlsen GK
Orlistat, phentermine/topiramate, naltrexone/bupropion, and the incretin-based drugs liraglutide and semaglutide, both GLP-1 receptor agonists (GLP-1RA), and tirzepatide, a biased dual GIP/GLP-1 receptor agonist, are currently both FDA and EMA approved for the management of non-syndromic obesity 10
potency declines to ~60% by day 35 at 2025C Store in amber or opaque vials to protect from light Reconstituted Solutions: Refrigerated Storage: 28C for 12 weeks